- RecruitingPHASE2
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
This study is looking at a new medicine called inebilizumab for children aged 2-17 with a muscle weakness condition called generalized Myasthenia Gravis (gMG). Researchers want to understand how the medicine works in the body and if it's safe.
For: Generalized Myasthenia GravisUnited States · France · Spain - Active not recruitingPHASE3
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
This study is looking into a new treatment called inebilizumab for a condition called IgG4-Related Disease. It aims to see if this treatment can stop flare-ups of the disease and if it's safe to use.
For: IgG4 Related DiseaseUnited States · Argentina · Australia - RecruitingPHASE2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
This study is looking at a new medicine called inebilizumab for children and teenagers aged 2-17 with a rare condition called Neuromyelitis Optica Spectrum Disorder (NMOSD). It will check how the medicine works, how safe it is, and what effects it has on the body.
For: Neuromyelitis Optica Spectrum DisorderUnited States · Argentina · Brazil - Not yet recruitingPHASE4
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
This study compares five medicines for Neuromyelitis Optica Spectrum Disorder (NMOSD) affecting the eyes and spinal cord. It aims to find which treatment best prevents relapses and has the fewest side effects for adults with NMOSD.
For: NMOSDUnited States · Germany - RecruitingPHASE2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
This study looks at new treatments (inebilizumab and blinatumomab) for people with Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). It mainly checks how safe these medicines are and if they help reduce symptoms of these conditions.
For: Systemic Lupus Erythematosus · Active Refractory Rheumatoid ArthritisUnited States · Australia · Belgium